Financial performance and economic value added: the case of a pharmaceutical company
Purpose: To analyze leading Mexican pharmaceutical company Genomma Lab's financial performance by examining its value creation from 2010 to 2020. Method: A case study approach is employed, incorporating an analysis of Porter's Five Forces, the calculation of Economic Value Added (EVA) alo...
Saved in:
| Main Authors: | Gerardo Flores Nava, María Luisa Saavedra García, María del Rosario Cortes Castillo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Universidad de Concepción
2025-07-01
|
| Series: | RAN |
| Subjects: | |
| Online Access: | https://revistas.udec.cl/index.php/ran/article/view/14293 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
FINANCIAL ANALYSIS OF PHARMACEUTICAL COMPANIES
by: E. Sedova, et al.
Published: (2016-10-01) -
Impact of corporate social responsibility on companie’s value creation: evidence from listed Moroccan companies
by: Lamia El Badri, et al.
Published: (2025-06-01) -
Link stability metric based on mobility prediction model in mobile ad hoc networks
by: ZHANG Hui1, et al.
Published: (2007-01-01) -
ANALYSIS OF PHARMACEUTICAL COMPANIES’ ACTIVITIES THAT ARE DIRECTED TO PHYSICIANS IN EGYPT
by: M. M. Bahlol, et al.
Published: (2016-03-01) -
METHODOLOGICAL APPROACHES TOWARDS THE ASSORTMENT MANAGEMENT IN PHARMACEUTICAL ORGANIZATION OF FAR EAST
by: S. Yu. Meshalkina
Published: (2015-10-01)